Antimicrobial peptide PK34 modification enhances the antibacterial and anti-inflammatory effects of bone-derived mesenchymal stem cells in Mycobacterium tuberculosis infection.

Saved in:
Bibliographic Details
Title: Antimicrobial peptide PK34 modification enhances the antibacterial and anti-inflammatory effects of bone-derived mesenchymal stem cells in Mycobacterium tuberculosis infection.
Authors: He XY; School of Medical Laboratory, Shandong Second Medical University, Weifang, Shandong, 261053, China.; Advanced Academy Engineering Research Institute for Precision Medicine innovation and Transformation of Infectious Disease, Weifang, Shandong, 261053, China., Wang JQ; State Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, 102206, China., Chen Y; School of Medical Laboratory, Shandong Second Medical University, Weifang, Shandong, 261053, China.; Advanced Academy Engineering Research Institute for Precision Medicine innovation and Transformation of Infectious Disease, Weifang, Shandong, 261053, China., Yuan TX; Shandong Provincial Hospital Heze Branch, Heze, Shandong, 274000, China., Zhao X; School of Medical Laboratory, Shandong Second Medical University, Weifang, Shandong, 261053, China.; Advanced Academy Engineering Research Institute for Precision Medicine innovation and Transformation of Infectious Disease, Weifang, Shandong, 261053, China., Sun YJ; School of Medical Laboratory, Shandong Second Medical University, Weifang, Shandong, 261053, China.; Advanced Academy Engineering Research Institute for Precision Medicine innovation and Transformation of Infectious Disease, Weifang, Shandong, 261053, China., Liu YM; School of Medical Laboratory, Shandong Second Medical University, Weifang, Shandong, 261053, China.; Advanced Academy Engineering Research Institute for Precision Medicine innovation and Transformation of Infectious Disease, Weifang, Shandong, 261053, China., Wang ZY; School of Medical Laboratory, Shandong Second Medical University, Weifang, Shandong, 261053, China.; Advanced Academy Engineering Research Institute for Precision Medicine innovation and Transformation of Infectious Disease, Weifang, Shandong, 261053, China., Cai YB; School of Medical Laboratory, Shandong Second Medical University, Weifang, Shandong, 261053, China.; Advanced Academy Engineering Research Institute for Precision Medicine innovation and Transformation of Infectious Disease, Weifang, Shandong, 261053, China., Gao W; School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, 261053, China., Cui CP; State Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, 102206, China., Yi ZJ; School of Medical Laboratory, Shandong Second Medical University, Weifang, Shandong, 261053, China. fuyizhengjun@163.com.; Advanced Academy Engineering Research Institute for Precision Medicine innovation and Transformation of Infectious Disease, Weifang, Shandong, 261053, China. fuyizhengjun@163.com., Li Q; School of Medical Laboratory, Shandong Second Medical University, Weifang, Shandong, 261053, China. liqian@sdsmu.edu.cn.; Advanced Academy Engineering Research Institute for Precision Medicine innovation and Transformation of Infectious Disease, Weifang, Shandong, 261053, China. liqian@sdsmu.edu.cn.
Source: Stem cell research & therapy [Stem Cell Res Ther] 2025 Aug 29; Vol. 16 (1), pp. 469. Date of Electronic Publication: 2025 Aug 29.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101527581 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-6512 (Electronic) Linking ISSN: 17576512 NLM ISO Abbreviation: Stem Cell Res Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1757-6512
DOI:10.1186/s13287-025-04596-9